Page last updated: 2024-11-12
4-hydroxy-5-azaphenanthrene
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
4-hydroxy-5-azaphenanthrene: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 11816407 |
SCHEMBL ID | 319465 |
MeSH ID | M0235891 |
Synonyms (28)
Synonym |
---|
10-hydroxybenzo[h]quinoline , |
H0738 |
33155-90-7 |
AKOS005255046 |
benzo[h]quinolin-10-ol |
A821638 |
4-hydroxy-5-azaphenanthrene |
benzo(h)quinolin-10-ol |
10-hydroxy-benzo[h]quinoline |
FT-0607191 |
SCHEMBL319465 |
10-hydroxybenzo [h] quinoline |
KESRRRLHHXXBRW-UHFFFAOYSA-N |
mfcd00142350 |
benzo[h]quinolin-10(1h)-one |
1h,10h-cyclohexa[h]quinolin-10-one |
1h-benzo[h]quinolin-10-one |
ams_cnc_id-517303614 |
smssf-0625121 |
10-hydroxybenzo(h)quinoline |
AS-13407 |
CS-W015722 |
142506-60-3 |
AMY18363 |
DTXSID40954770 |
SB66632 |
5-hydroxy-4-azaphenanthrene |
SY036849 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.75
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.75) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |